Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice.
Aitken, Jacqueline F
Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice. [electronic resource] - Biochemical and biophysical research communications Jan 2017 - 625-631 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2016.11.083 doi
Amyloid--genetics
Animals
Blood Glucose--metabolism
Diabetes Mellitus, Experimental--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Humans
Hypoglycemic Agents--pharmacology
Islet Amyloid Polypeptide--genetics
Islets of Langerhans--drug effects
Male
Mice, Transgenic
Protein Aggregation, Pathological--drug therapy
Protein Folding--drug effects
Proteostasis Deficiencies--drug therapy
Rutin--pharmacology
Rutin suppresses human-amylin/hIAPP misfolding and oligomer formation in-vitro, and ameliorates diabetes and its impacts in human-amylin/hIAPP transgenic mice. [electronic resource] - Biochemical and biophysical research communications Jan 2017 - 625-631 p. digital
Publication Type: Journal Article
1090-2104
10.1016/j.bbrc.2016.11.083 doi
Amyloid--genetics
Animals
Blood Glucose--metabolism
Diabetes Mellitus, Experimental--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Humans
Hypoglycemic Agents--pharmacology
Islet Amyloid Polypeptide--genetics
Islets of Langerhans--drug effects
Male
Mice, Transgenic
Protein Aggregation, Pathological--drug therapy
Protein Folding--drug effects
Proteostasis Deficiencies--drug therapy
Rutin--pharmacology